Announcements

CorMedix Inc. filed a current report on November 9, 2026, disclosing an Asset Purchase Agreement signed November 8, 2026, under which the company agreed to acquire substantially all assets of Heron Therapeutics, Inc. for a combination of cash, stock, royalties, and contingent earn-out payments.

Robbins LLP announced on November 9, 2026, that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Tigo Energy (NASDAQ:TYGO) securities between February 24, 2026 and August 4, 2026.

Director Paul W. Harvey filed a Form 4 with the SEC on November 9, 2026, disclosing a purchase of 500 shares of Matador Resources Co common stock on November 5, 2026, at a price of $52.72 per share.

SciSparc Ltd. filed a Form 6-K/A on November 9, 2026, amending its November 3, 2026 Form 6-K to correct a typographical error in the Floor Price contained in a Convertible Promissory Note and related Warrant issued to L.I.A. Pure Capital Ltd.

Davion Healthcare Plc filed a Form 6-K on November 9, 2026, disclosing that it entered into a non-exclusive financial advisory agreement with Vienna Capital Partners LLC to support a proposed acquisition financing strategy for 2027.

Heron Therapeutics, Inc. filed a Form 8-K on November 9, 2026, disclosing that on November 8, 2026, it entered into an Asset Purchase Agreement with CorMedix Inc. to sell substantially all of its assets for a combination of cash, stock, royalties, and potential earn-out …

Joseph Wm. Foran, Chairman and CEO of Matador Resources Co, filed a Form 4 with the SEC on November 9, 2026, disclosing an open-market purchase of 5,000 shares of common stock on November 5, 2026, at a weighted average price of $51.36 per share.